Long-time partner invests in shared vision for personalized health and wellness: Cristiano Ronaldo invests $7.5 million in Pro2col™ Technology, acquires 10% equity stake.
Los Angeles, CA – Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced global sports icon Cristiano Ronaldo acquired a 10% equity interest in HBL Pro2col™ Software, LLC, an indirect wholly-owned subsidiary of Herbalife that holds the Pro2col™ technology.
Pro2col is Herbalife’s next-generation, digital, personalized health and wellness operating system, designed to drive daily engagement, sustainable behavior change, and measurable outcomes through a structured, data-driven approach to wellness.
Ronaldo invested $7.5 million, along with a commitment to provide services and sponsorship rights to Pro2col Software. The investment underscores Ronaldo’s deep personal commitment to health and nutrition. It also reflects his confidence in the future of personalized nutrition and Herbalife’s ambition to make data-driven, personalized wellness accessible to communities globally — combining innovative technology with the power of personal support through its distributor community.
Herbalife Announces Cristiano Ronaldo Invests $7.5 Million in Pro2col™ Technology, Acquires 10% Equity Stake
Herbalife has been Ronaldo’s global nutrition partner since 2013, inspiring better nutrition and performance globally. Herbalife and Ronaldo collaborated on the launch of Herbalife24® CR7 Drive, a sports drink formulated to
Tag Archive for Nutrition Innovation
Hot Business News Today
Zinzino Acquires 35% Shares in Xion International Group
by Press Release • • 0 Comments
Zinzino AB (publ.): Zinzino acquires 35% of the shares in Andorra-based Xion International Group for further development of its own-produced omega-3 oil and spirulina.
Zinzino announced in a press release on July 11, 2025, that the company had initiated a process to acquire 35% of Xion International Group with the aim of forming a joint venture to produce algae using bioreactors. Zinzino has now completed the first step in the process and acquired 35% of the shares in Xion. Together, the next step in the joint project to develop the cultivation method and production of microalgae in a joint venture, in which Zinzino owns 55% of the shares, is now being initiated in order to secure a future sustainable supply of omega-3 for the company’s main product, BalanceOil+; a polyphenol-rich, omega-balancing dietary supplement.
This is a very important strategic initiative to meet the increased demand for the product arising from Zinzino‘s global expansion and high sales growth.
Xion is an innovative production company with its own patents based in Spain that has developed one of the world’s first high-tech photobioreactor systems for the production of the nutrient-rich microalgae spirulina. Xion’s groundbreaking, award-winning technology, with a cultivation method based on nature’s own principles, sets